SIRT6 belongs to the mammalian homologs of Sir2 histone NAD+-dependent deacylase family. In rodents, SIRT6 deficiency leads to aging-associated degeneration of mesodermal tissues. It remains unknown whether human SIRT6 has a direct role in maintaining the homeostasis of mesodermal tissues. To this end, we generated SIRT6 knockout human mesenchymal stem cells (hMSCs) by targeted gene editing. SIRT6-deficient hMSCs exhibited accelerated functional decay, a feature distinct from typical premature cellular senescence. Rather than compromised chromosomal stability, SIRT6-null hMSCs were predominately characterized by dysregulated redox metabolism and increased sensitivity to the oxidative stress. In addition, we found SIRT6 in a protein complex with both nuclear factor erythroid 2-related factor 2 (NRF2) and RNA polymerase II, which was required for the transactivation of NRF2-regulated antioxidant genes, including heme oxygenase 1 (HO-1). Overexpression of HO-1 in SIRT6-null hMSCs rescued premature cellular attrition. Our study uncovers a novel function of SIRT6 in maintaining hMSC homeostasis by serving as a NRF2 coactivator, which represents a new layer of regulation of oxidative stress-associated stem cell decay.
PTEN is a tumour suppressor frequently mutated in many types of cancers. Here we show that targeted disruption of PTEN leads to neoplastic transformation of human neural stem cells (NSCs), but not mesenchymal stem cells. PTEN-deficient NSCs display neoplasm-associated metabolic and gene expression profiles and generate intracranial tumours in immunodeficient mice. PTEN is localized to the nucleus in NSCs, binds to the PAX7 promoter through association with cAMP responsive element binding protein 1 (CREB)/CREB binding protein (CBP) and inhibits PAX7 transcription. PTEN deficiency leads to the upregulation of PAX7, which in turn promotes oncogenic transformation of NSCs and instates ‘aggressiveness' in human glioblastoma stem cells. In a large clinical database, we find increased PAX7 levels in PTEN-deficient glioblastoma. Furthermore, we identify that mitomycin C selectively triggers apoptosis in NSCs with PTEN deficiency. Together, we uncover a potential mechanism of how PTEN safeguards NSCs, and establish a cellular platform to identify factors involved in NSC transformation, potentially permitting personalized treatment of glioblastoma.
The Wnt/β-catenin signaling pathway plays important roles in the progression of colon cancer.
DACT1
has been identified as a modulator of Wnt signaling through its interaction with Dishevelled (Dvl), a central mediator of both the canonical and noncanonical Wnt pathways. However, the functions of
DACT1
in the WNT/β-catenin signaling pathway remain unclear. Here, we present evidence that
DACT1
is an important positive regulator in colon cancer through regulating the stability and sublocation of β-catenin. We have shown that
DACT1
promotes cancer cell proliferation
in vitro
and tumor growth
in vivo
and enhances the migratory and invasive potential of colon cancer cells. Furthermore, the higher expression of
DACT1
not only increases the nuclear and cytoplasmic fractions of β-catenin, but also increases its membrane-associated fraction. The overexpression of
DACT1
leads to the increased accumulation of nonphosphorylated β-catenin in the cytoplasm and particularly in the nuclei. We have demonstrated that
DACT1
interacts with GSK-3β and β-catenin.
DACT1
stabilizes β-catenin via
DACT1
-induced effects on GSK-3β and directly interacts with β-catenin proteins. The level of phosphorylated GSK-3β at Ser9 is significantly increased following the elevated expression of
DACT1
.
DACT1
mediates the subcellular localization of β-catenin via increasing the level of phosphorylated GSK-3β at Ser9 to inhibit the activity of GSK-3β. Taken together, our study identifies
DACT1
as an important positive regulator in colon cancer and suggests a potential strategy for the therapeutic control of the β-catenin-dependent pathway.
We have studied plasma waveguiding in soft x-ray laser experiments. A curved-slab target was used in order to compensate for x-ray refraction in a gradient-density plasma. In addition to significant increase in the x-ray laser intensity in single-pass amplification, a small beam divergence of less than 1 mrad has been stably generated in double-pass amplification with the curved target. The angular intensity distribution of the double-passed beam indicates that the x-ray laser has been amplified in a plasma waveguide. PACS numbers: 42.55.Vc, 41.50.+h, 52.40.Fd X-ray lasers with high coherent power are required for various applications such as holography [1,2], plasma diagnostics [3], holographic nanolithography [4], and nonlinear x-ray optics [5]. Most of the x-ray laser schemes now operating, especially the collisional excitation x-ray lasers [6], use laser-produced plasmas with high electron density. The major difficulty in improving the spatial co-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.